Rupture of fetal membranes (ROM) can initiate parturition at both term and preterm. Collagen III in the compact layer of the amnion contributes to the tensile strength of fetal membranes. However, the upstream signals triggering collagen III degradation remain mostly elusive. In this study, we investigated the role of cortisol regenerated by 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) in collagen III degradation in human amnion fibroblasts with an aim to seek novel targets for the prevention of preterm premature ROM (pPROM)-elicited preterm birth. Human amnion tissue and cultured amnion tissue explants and amnion fibroblasts were used to study the regulation of collagen III, which is composed of three identical 3α 1 chains (COL3A1), by cortisol. Cortisol decreased COL3A1 protein but not mRNA abundance in a concentrationdependent manner. Cortisone also decreased COL3A1 protein, which was blocked by 11β-HSD1 inhibition. The reduction in COL3A1 protein by cortisol was not affected by a transcription inhibitor but was further enhanced by a translation inhibitor. Autophagic pathway inhibitor chloroquine or siRNA-mediated knock-down of ATG7, an essential protein for autophagy, failed to block cortisol-induced reduction in COL3A1 protein abundance, whereas proteasome pathway inhibitors MG132 and bortezomib significantly attenuated cortisol-induced reduction in COL3A1 protein abundance. Moreover, cortisol increased COL3A1 ubiquitination and the reduction of COL3A1 protein by cortisol was blocked by PYR-41, a ubiquitin-activating enzyme inhibitor. Conclusively, cortisol regenerated in amnion fibroblasts may be associated with ROM at parturition by reducing collagen III protein abundance through a ubiquitin-proteasome pathway.
Introduction
Preterm birth (<37 weeks) occurs in approximately 10% of all pregnancies, which claims millions of neonatal casualties each year (Blencowe et al. 2012) . Preterm premature rupture of fetal membranes (pPROM) accounts for about one-third of the preterm births (Slattery & Morrison 2002) . Therefore, delineating the mechanism underlying membrane rupture may provide novel targets for the prevention of preterm birth. Human fetal membranes are composed of amnion and chorion. The tensile strength of the fetal membranes mainly derives from the collagen contents in the compact layer of the amnion, which is predominantly constituted of types I and III together with small amounts of types IV, V and VI collagens (Malak et al. 1993 , Parry & Strauss 1998 , Oyen et al. 2006 . The quantitatively major collagen types I and III form parallel collagen bundles, while the minor collagen types IV, V and VI provide a scaffold for the assembly of other mesenchymal components, form filament connections with types I and III collagens or provide an additional anchoring function for types I and III (Bryant-Greenwood 1998) . Previous studies have shown that the abundance of collagens in the fetal membranes decreases with advancing gestational age, and further decreases in pPROM (Skinner et al. 1981 , Kumar et al. 2016 , suggesting that decreased collagen abundance in the fetal membranes plays a crucial role in the ROM. The causes for collagen reduction are believed to be largely ascribed to extracellular degradation by matrix metalloproteinases (MMPs) (Athayde et al. 1998 , Strauss 2013 , whereas very little is known about collagen degradation through lysosome and proteasome pathways.
The fetal membranes possess the largest cortisolregenerating capacity among fetal tissues in late gestation (Murphy 1981) . The expression of cortisol-regenerating enzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) has been found in virtually all cell types in the membranes (Sun & Myatt 2003) with its expression increasing with gestational age (Alfaidy et al. 2003) . Intriguingly, in contrast to the conventional negative feedback of products on enzymes, cortisol induces 11β-HSD1 expression in the fetal membranes, thus forming a local feedforward loop of cortisol regeneration toward the end of gestation (Sun & Myatt 2003 , Yang et al. 2007 ). The functional role of this unique feature of cortisol regeneration in the fetal membranes remains elusive. Accumulating evidence indicates that in addition to the induction of prostaglandin synthesis (Casey et al. 1985 , Zhu et al. 2009 , Wang et al. 2015 , cortisol regenerated by 11β-HSD1 may also be involved in extracellular matrix structure remodeling via induction of amnion epithelial cell apoptosis , inhibition of collagen cross-linking enzyme lysyl oxidase ) and degradation of collagen I in amnion fibroblasts (Mi et al. 2017) . Of interest, autophagic pathway is revealed to be associated with cortisol-induced collagen I degradation (Mi et al. 2017) . However, we are unclear whether cortisol regeneration is also engaged in the degradation of collagen III, another major collagen type in the amnion compact layer. Given the reported roles of glucocorticoids in lysosome and proteasome-mediated protein degradation in a number of tissues including the amnion (Hopgood et al. 1981 , Hasan et al. 2012 , Yao et al. 2013 , Mi et al. 2017 , we hypothesize that cortisol regeneration by 11β-HSD1 may also participate in collagen III degradation through these pathways in amnion fibroblasts, the major source of collagens in the amnion compact layer, thereby devastating the major collagen bundles in the amnion resulting in the rupture of membranes. Here, we examined this hypothesis in human amnion tissue and fibroblasts.
Materials and methods

Collection of human fetal membranes
Human fetal membranes were obtained from uncomplicated term (38-40 weeks) pregnancies after elective cesarean section without labor (non-labor) or after vaginal delivery with spontaneous rupture of the membranes (labor). Written informed consent was obtained from the participating patients under a protocol approved by the Ethics Committee of Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University. Pregnancies with complications such as preeclampsia, fetal growth restriction, gestational diabetes and chorioamnionitis were excluded from this study.
Extraction of protein from the human amnion tissue
To study the changes of collagen III abundance in the amnion tissue in parturition, the fetal membranes were collected from deliveries with spontaneous rupture of membranes at labor (n = 7) or without labor at elective c section (n = 9). The demographic characteristics of patients are given in Table 1 . The amnion was peeled off the chorion and was cut within 5 cm of the spontaneous 
Preparation of human amnion tissue explants
Human amnion tissue explants were prepared from the amnion collected from patients with elective c section without labor at term (n = 3). The amnion was cut in circles using a 6-mm skin biopsy puncher and then placed in Falcon cell culture inserts (Becton Dickinson, Franklin Lakes, NJ, USA) in a 6-well plate in culture medium containing 1:1 mixture of Ham's F12: Dulbecco's Modified Eagle Medium (DMEM), 10% fetal bovine serum (FBS) and 1% antibiotics (Life Technologies). The explants were equilibrated at 37°C in 5% CO 2 /95% air for 24 h. The explants were then treated with cortisol (1 μM; Sigma) in phenol red/serum-free medium for 24 h and the explants were collected for protein extraction as described above for collagen III protein determination with Western blotting.
Preparation of human amnion fibroblasts
Human amnion fibroblasts were isolated from the amnion collected from patients with elective c section without labor at term (n = 43). After peeling off the chorion, the amnion tissue was digested twice with 0.125% trypsin (Life Technologies) for 20 min to remove epithelial cells, and then washed vigorously to remove residual epithelial cells. The remaining amnion tissue was digested with 0.1% collagenase (Sigma) for 18 min to release the fibroblasts from the mesenchymal tissue. The digestion medium was centrifuged at 1000 g, 10 min, 4°C, and the pellet was re-suspended in DMEM and layered on Percoll (GE Healthcare Bio-Sciences) gradients (5, 20, 40 and 60%) for further purification of the fibroblasts. After washing, the purified fibroblasts were cultured at 37°C in 5% CO 2 /95% air in DMEM containing 10% FBS plus 1% antibiotics (Life Technologies). The identity of cells was verified by immunofluorescent staining for mesenchymal cell marker vimentin, epithelial marker cytokeratin and leukocyte marker CD45, and more than 95% of the cells were vimentin-positive.
Immunofluorescent staining of human amnion fibroblasts
The cells were plated in Chamber Polystyrene Vessels (BD Falcon, Franklin Lakes, NJ, USA). Three days after culture in DMEM containing 10% FBS, the cells were fixed with 4% paraformaldehyde and permeabilized with 0.4% Triton X-100 for immunofluorescence staining. The cells were blocked with normal goat serum (Jackson ImmunoResearch Laboratories) and then incubated with primary antibodies at 1:100 dilutions against vimentin (Santa Cruz Biotechnology), cytokeratin (Santa Cruz Biotechnology) and CD45 (Abcam) overnight at 4°C. After washing with PBS, Alexa Fluor 488 (green)-and Alexa Fluor 594 (red)-labeled secondary antibodies (1:100; Proteintech) were applied in darkness at room temperature for 2 h. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue color) (1 μg/mL). The staining was examined using a fluorescence microscope (Zeiss).
Treatment of human amnion fibroblasts
Three days after plating, amnion fibroblasts were treated with the following reagents in phenol red/FBS-free culture medium for 24 h unless specified. To examine concentration-dependent effects of cortisol on collagen III mRNA and protein abundance, cortisol (0.01, 0.1 and 1 µM) was added to fibroblasts. To examine whether the effect of cortisol on collagen III abundance occurred at the transcriptional or translational level, fibroblasts were treated with cortisol (1 µM) in the presence or absence of the transcription inhibitor 5,6-dichloro-1-beta-Dribofuranosylbenzimidazole (DRB) (1 µM; Sigma) or the translation inhibitor cycloheximide (CHX) (1 µM; Sigma). To examine the role of glucocorticoid receptor (GR) in the regulation of collagen III abundance by cortisol, the cells were treated with cortisol (1 µM) in the presence or absence of GR antagonist RU486 (1 µM, Sigma) or small interfering RNA (siRNA)-mediated knock-down of GR. To examine the involvement of 11β-HSD1 in the regulation of collagen III abundance, fibroblasts were treated with cortisone (5 µM; Sigma) in the presence or absence of 11β-HSD1 inhibitor 10j (1 µM; Millipore) or siRNAmediated knock-down (GenePharma, Shanghai, China) of 11β-HSD1. To examine the involvement of lysosome and proteasome pathways in the degradation of collagen III, fibroblasts were treated with cortisol (1 µM) in the presence or absence of a lysosome pathway inhibitor chloroquine (CQ) (50 µM; Sigma) or proteasome pathway inhibitors MG132 (10 nM; Selleck, Houston, TX, USA) Journal of Molecular Endocrinology and bortezomib (50 nM; Selleck) or a ubiquitin-activating Enzyme E1 inhibitor PYR-41 (5 µM; Selleck). The involvement of lysosome pathway was further examined with siRNA-mediated knock-down of autophagy-related protein 7 (ATG7) (Comincini et al. 2013) . After the aforementioned treatments, collagen III mRNA or protein abundance was determined with quantitative real-time PCR (qRT-PCR) or Western blotting.
Transfection of siRNA in amnion fibroblasts with electroporation
To study the role of 11β-HSD1 and GR in the regulation of collagen III by glucocorticoids, fibroblasts were transfected with 50 nM siRNA (GenePharma) against 11β-HSD1 (5′-CACCAACACUUCUUUGAAUTT-3′) or GR (5′-GCAGCCAGAUCUGUCCAAATT-3′). To study the role of ATG7 in cortisol-induced COL3A1 protein degradation, fibroblasts were transfected with 50 nM siRNA (GenePharma) targeting ATG7 (5′-GCCUCUCUAUGAGUUUGAATT-3′).
Randomly scrambled siRNA (5-UUCUCCGAACGUGUCACGUTT-3) served as control. The cells were transfected using an electroporator at 175 V for 5 ms as described previously (Wang et al. 2015) and then incubated in DMEM containing 10% FBS and 1% antibiotics for three days before treatments. The efficiency of knock-down was assessed by measuring target proteins with Western blotting, and was shown to be 75, 70 and 65% for 11β-HSD1, GR and ATG7, respectively.
Quantitative real-time PCR
After treatment, total RNA was extracted from the cells and reverse-transcribed to cDNA using a commercial kit (TaKaRa). Since collagen III consists of three identical α1 chains (COL3A1) ], the amounts of COL3A1 mRNA were determined by qRT-PCR using the above-transcribed cDNA and power SYBR Premix Ex Taq (TaKaRa) as described previously (Wang et al. 2015) . The absolute mRNA abundance in each sample was calculated from a standard curve setup using serial dilutions of known amounts of specific templates generated by PCR against corresponding cycle threshold values. Housekeeping gene GAPDH was amplified in parallel as an internal control. The primer sequences are as follows: COL3A1, forward 5′-CCTGCTGGAGAGCGTGGTGC, reverse 5′-TGACTTCCGGGAGGCCCTGG; GAPDH, forward 5′-CCCCTCTG CTGATGCCCCCA-3′, reverse 5′-TGACCTTGGCCAGGGGTGCT-3′. The ratio of the target gene over GAPDH in each sample was obtained as an indication of the target gene expression.
Western blotting
After treatment, the cells were lysed in ice-cold RIPA lysis buffer (Active Motif) containing a protease inhibitor cocktail (Sigma). After determination of protein concentration, the extracted protein was analyzed with Western blotting following a standard protocol using primary antibodies against COL3A1 (1:1000, Novus, Littleton, CO, USA), COL1A1 (a major chain of collagen I, 1:1000, Novus), ATG7 (1:1000, Cell Signaling), GR (1:1000, Santa Cruz Biotechnology) and 11β-HSD1 (1:500, Abcam). Internal loading controls were probed with antibodies against GAPDH (1:5000, Proteintech, Rosemont, IL, USA) or β-Actin (1:10000, Proteintech). The bands were visualized using a G-Box iChemi Chemiluminescence image capture system (Syngene, Cambridge, UK). The ratio of band intensities of COL3A1, COL1A1, ATG7, GR and 11β-HSD1 over GAPDH or β-actin was obtained, respectively, as a measure of target protein abundance.
Examination of COL3A1 ubiquitination
To examine the ubiquitination of COL3A1 protein, the fibroblasts were treated with cortisol (1 µM) in the presence of MG132 (10 nM) for 24 h and then lysed in non-denaturing cell lysis buffer (Cell Signaling) containing 1 mM PMSF (Cell Signaling) on ice. A small amount of lysate was aspirated to serve as an input control and the remaining lysate was incubated with protein A/G agarose beads for 1.5 h at 4°C. After centrifugation at 60 g, 5 min, 4°C, the supernatant was divided into two parts for further incubation with COL3A1 antibody (4 µg) or non-immune rabbit IgG (4 µg) overnight at 4°C. Protein A/G agarose beads were then added again for further incubation for 1.5 h at 4°C. After centrifugation at 60 g, 5 min, 4°C, the beads in the pellet were washed with the non-denaturing cell lysis buffer. Then, 25 µL of 2 × Western blotting loading buffer was added to the washed beads and the solution was boiled for 5 min. After centrifugation at 13,000 g, 30 s, 25°C, the supernatant was collected for analysis with Western blotting along with the input control. The ubiquitinated COL3A1 was detected with an antibody against ubiquitin (1:1000, Cell Signaling).
Statistical analysis
All data are reported as mean ± s.e.m. The number in each study represents separate experiments using amnion cells prepared from different pregnancies. Statistical analysis was performed with paired or unpaired Student's t-test or one-way ANOVA test followed by the Newman-Keuls Multiple Comparison Test where appropriate. Significance was set at P < 0.05.
Results
Reduction in COL3A1 protein abundance in the human amnion tissue at parturition
The demographic characteristics of patients with spontaneous labor and rupture of membranes or without labor at elective c section are given in Table 1 . COL3A1 protein abundance in the amnion tissue was significantly decreased in labor with spontaneous rupture of membranes when compared with elective c section without labor (Fig. 1A) . Heterogeneity in COL3A1 protein abundance was observed within both groups. We are not clear what causes the heterogeneity at present. It may be due to some subclinical unidentified reasons.
Reduction in COL3A1 protein abundance in human amnion tissue explants by cortisol
Treatment of human amnion tissue explants with cortisol (1 µM) significantly decreased COL3A1 protein abundance (Fig. 1B) , indicating that cortisol regeneration may contribute to the reduction of COL3A1 protein in the amnion at parturition.
Cortisol decreases COL3A1 protein but not mRNA in human amnion fibroblasts
Immunofluorescent staining showed that more than 95% of the cells isolated from the amnion are vimentin-positive fibroblasts rather than cytokeratin-positive epithelial cells or CD45-positive leukocytes (Fig. 2) . Treatment of amnion fibroblasts with cortisol (0.01, 0.1 and 1 µM) had no effect on COL3A1 mRNA, but decreased COL3A1 protein in a concentration-dependent manner (Fig. 3A) . Time course (3, 6, 12 and 24 h) analysis confirmed the lack of effect of cortisol (1 µM) on COL3A1 mRNA and also the decreases in COL3A1 protein by cortisol at 12 and 24 h (Fig. 3B) . Cortisol (1 µM)-induced decreases in COL3A1 protein were still observed in the presence of the mRNA transcription inhibitor DRB (1 µM) (Fig. 3C ) and was further enhanced by the protein translation inhibitor CHX (1 µM) (Fig. 3D) . These data suggest that cortisol reduces COL3A1 protein abundance at the post-translational level.
Participation of GR in cortisol-induced decreases in COL3A1 protein in human amnion fibroblasts
Treatment of amnion fibroblasts with cortisol (1 µM) in the presence of either GR antagonist RU486 (1 µM) (Fig. 4A) or siRNA-mediated knock-down of GR (Fig. 4B) blocked the reduction in COL3A1 protein by cortisol, indicating the participation of GR in cortisol-induced reduction in COL3A1 protein.
Participation of 11β-HSD1 in cortisone-induced decreases in COL3A1 protein in human amnion fibroblasts
Treatment of amnion fibroblasts with cortisone (5 µM) in the presence of either 11β-HSD1 inhibitor 10j (1 µM) (Fig. 4C) or siRNA-mediated knock-down of 11β-HSD1 (Fig. 4D) significantly attenuated cortisone-induced 
Cortisol decreases COL3A1 protein via proteasome but not lysosome pathway in human amnion fibroblasts
The lysosome pathway inhibitor CQ (50 µM) (Fig. 5A) or siRNA-mediated knock-down of ATG7 (Fig. 5B) failed to block cortisol (1 µM)-induced reduction in COL3A1 protein, whereas the same treatments reversed cortisol (1 µM)-induced reduction in COL1A1 protein as reported earlier (Mi et al. 2017) . The proteasome pathway inhibitor MG132 (10 nM) (Fig. 5A ) could block cortisol (1 µM)-induced reduction in COL3A1 protein but not the reduction in COL1A1 protein. Furthermore, bortezomib (50 nM) (Fig. 5C ), another proteasome pathway inhibitor, and PYR-41 (5 µM), a ubiquitin-activating Enzyme E1 inhibitor (Fig. 5D) , could also block cortisol-induced reduction in COL3A1 protein. The ubiquitination of COL3A1 was increased by cortisol (1 µM) in the presence of MG132 (10 nM) in amnion fibroblasts (Fig. 6 ). However, a single band was observed above 170 kD in the sample precipitated by the COL3A1 antibody, suggesting that uniform ubiquitination of COL3A1 occurred. These data suggest that the ubiquitin-proteasome pathway rather than the lysosome pathway is involved in the degradation of COL3A1 by cortisol in human amnion fibroblasts.
Discussion
It remains a mystery why the fetal membranes evolve such an extraordinary capability of cortisol regeneration by 11β-HSD1 (Murphy 1977 (Murphy , 1981 . In this study, we have demonstrated that cortisol regeneration by 11β-HSD1 in human amnion fibroblasts participates in the degradation of COL3A1 protein via activation of the ubiquitin-proteasome system. Since the concentration of cortisol can reach up to 5 µM locally in the amnion tissue at parturition (Wang et al. 2015) , the concentration of cortisol used in this study is thus physiologically relevant. In light of a previous study showing that glucocorticoids inhibit collagen expression in human amnion epithelial cells (Guller et al. 1995) and our recent findings that cortisol regenerated by 11β-HSD1 degrades COL1A1 via an autophagic pathway (Mi et al. 2017) and decreases the expression of collagen cross-linking enzyme lysyl oxidase , we believe that local cortisol regeneration by 11β-HSD1 may play a pivotal role in the membrane rupture at parturition by reducing both collagen abundance and cross-linking. It has been noted for a long time that excessive glucocorticoids cause skin atrophy through collagen degradation (Schoepe et al. 2006 ) and inhibition of 11β-HSD1 improves agingrelated skin conditions (Tiganescu et al. 2013) . Given the demonstrated effects of cortisol regeneration on collagen degradation and cross-linking, we postulate that inhibition of 11β-HSD1 may also provide a potential therapeutic intervening approach in the prevention of premature preterm rupture of membranes.
Amnion fibroblasts, unlike amnion epithelial cells, are resistant to apoptosis induced by cortisol . It is thus unlikely that the degradation of collagens by cortisol is a consequence of apoptotic effects induced by cortisol in amnion fibroblasts. Although the data in the current study were obtained under cultured conditions in vitro, we believe that they are a reflection of in vivo situations since the degradation of COL3A1 by cortisol was reproducible in amnion tissue explants and was consistent with changes of COL3A1 abundance in the amnion tissue obtained from patients as well.
Our findings that cortisol degrades COL1A1 and COL3A1 through lysosome and proteasome pathways, respectively, appear to reconcile with previous studies showing that both ubiquitin-proteasome and autophagic lysosome pathways are activated during ROM (Cao et al. 2017 , Zhao et al. 2017 . Although collagens I and III comprise the backbone of the mesenchymal structure of the compact layer in the amnion, they may differ slightly in their functional roles in ECM remodeling. According to a report by Goel and coworkers, COL3A1 is elastic but COL1A1 is more rigid in the vasculature (Goel et al. 2013) . However, we are unclear why cortisol adopts differential mechanisms in the degradation of COL1A1 and COL3A1, which may be ascribed to the structure differences of these two types of collagen chains. This study presented evidence for the proteasome-mediated degradation of COL3A1 protein by cortisol in human amnion fibroblasts and the lysosomal pathway can be excluded in the degradation of COL3A1 protein by cortisol because the proteasome inhibitors MG132 and bortezomib could reverse the reduction in COL3A1 protein by cortisol, whereas the lysosomal inhibitor CQ or siRNA-mediated knock-down of ATG7 failed to block the reduction in COL3A1 protein by cortisol despite successful blockade of the reduction in cortisol-induced COL1A1 protein abundance. The involvement of proteasome pathway is further supported by the findings with a broad spectrum inhibitor of ubiquitination enzymes E1 PYR-41 (Inobe & Matouschek 2014) and the increase in COL3A1 ubiquitination upon cortisol treatment. Ubiquitination of proteins is normally associated with proteasome degradation of cellular proteins (Thrower et al. 2000) . Although GR is shown to mediate the degradation of COL3A1 protein by cortisol, how cortisol activates the ubiquitin-proteasome pathway via GR remains to be investigated in the future.
It should be kept in mind that multiple factors may contribute to the reduction of collagens in the fetal membranes toward the end of gestation. Apart from the revealed role of cortisol regeneration, a decline in the density of mesenchymal cells (Casey & MacDonald 1996) and accumulation of proinflammatory cytokines may also contribute to the reduction in collagen abundance in the fetal membranes during membrane rupture. Enhanced proinflammatory cytokine production has been observed in the fetal membranes at both infection-and noninfection-induced labor (Keelan et al. 2003 , GomezLopez et al. 2010 , Romero et al. 2014 , Lim et al. 2015 . Proinflammatory cytokines have been demonstrated to be potent activators of MMPs (Athayde et al. 1998 , Ben David et al. 2008 , which degrade extracellular collagens. It is well known that glucocorticoids are classical antiinflammatory hormones exerting potent inhibitory effects on proinflammatory cytokines and MMPs in other parts of the body (Vincenti & Brinckerhoff 2002 , Rhen & Cidlowski 2005 . Glucocorticoids have also been shown to inhibit proinflammatory cytokine expression in human 
